Fundraising Fox
🦊/Companies
Sign in

Ouro Medicines

South San Francisco, US · Founded 2024 · 20 employees on LinkedIn · 10 known investors

Find your way into Ouro Medicines

103 people in our graph share verified history with the Ouro Medicines team — schools, employers, funds. One of them is your warm intro.

Laura Quockunlockedknows Neely Mozaffarian · together at AbbVie (overlapped)
×8knows the team · via AbbVie
knows the team · via Ichnos Sciences
knows the team · via Fate Therapeutics
knows the team · via Albert Einstein College of Medicine

Ouro Medicines is a biotechnology company developing cell-depleting therapies aimed at resetting the immune system to treat chronic immune-mediated diseases such as autoimmune and autoinflammatory conditions. It is advancing a pipeline of biologics and small molecules across immunology and related therapeutic areas.

BiotechHealthtech

Founders & leadership

Ouro Medicines was founded in 2024 by Jaideep.

J
JaideepFounding Chief Executive Officer
NMNeely Mozaffarian
Neely MozaffarianinChief Medical Officerwith subspecialty training in rheumatology and internal medicine, along with a Ph.D. in microbiology and immunology; he brings pharmaceutical R&D experience in autoimmune and inflammatory diseases across clinical trial phases.
CChristina
ChristinaGeneral Counsel & Chief Operating Officer

Investors · 10

Monograph Capital PartnersLondon
New Enterprise Associates (NEA)Menlo Park · $200K – $40M
Norwest Venture PartnersMenlo Park · $10M – $30M
TPGreportedSan Francisco

Also in the syndicate · 6

Boyu/Zoo CapitalGSKGSK plcLongRiver InvestmentsTPG Life Sciences InnovationsleadUPMC Enterprises

Funding

SEC filings, press & company announcements

$240M disclosed across 2 rounds · 2025

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

2 people who came through Ouro Medicines went on to found or lead other companies.

Tim FunnellInvestor DirectorFounded Ascend Advanced TherapiesKristina NebelExecutive AssistantFounded Walking Fish Therapeutics

In the news

Ouro Medicines Launches with $120M Funding to Advance Immune Reset Therapies - PharmaSourcepharmasource.global · Jan 2025Ouro Medicines: $120 Million Raised For Developing Immune Reset Therapeuticspulse2.com · Jan 2025Ouro Medicines, backed by GSK and Monograph Capital, raises $120 million with 'Goldilocks' reset of immune system - San Francisco Business Timesbizjournals.com · Jan 2025Ouro Medicines Launches to Define the Future of Treatment for People with Immune-Mediated Diseasesprnewswire.com · Jan 2025Ouro Medicines Raises $120M in Series A Fundingfinsmes.com · Jan 2025Ouro Medicines 1/10/2025 Capital Raise - Gaebler.com Venture Capital Databasegaebler.com

Frequently asked questions

What does Ouro Medicines do?
Ouro Medicines is a biotechnology company developing cell-depleting therapies aimed at resetting the immune system to treat chronic immune-mediated diseases such as autoimmune and autoinflammatory conditions. It is advancing a pipeline of biologics and small molecules across immunology and related therapeutic areas.
Who founded Ouro Medicines?
Ouro Medicines was founded by Jaideep in 2024.
Who are Ouro Medicines's investors?
Ouro Medicines's investors include Monograph Capital Partners, New Enterprise Associates (NEA), Norwest Venture Partners, TPG.
How much funding has Ouro Medicines raised?
Ouro Medicines has disclosed $240M raised across 2 rounds.
Where is Ouro Medicines headquartered?
Ouro Medicines is headquartered in South San Francisco, US.